Ellingson Rachel 4
4 · ZIMMER BIOMET HOLDINGS, INC. · Filed Feb 27, 2024
Insider Transaction Report
Form 4
Ellingson Rachel
SVP & Chief Strategy Officer
Transactions
- Exercise/Conversion
Common Stock
[F1][F2]2024-02-25+1,762→ 6,460 total - Tax Payment
Common Stock
[F3]2024-02-25$128.80/sh−588$75,734→ 5,872 total - Exercise/Conversion
Restricted Stock Units
[F4][F1]2024-02-25−1,762→ 0 totalFrom: 2024-02-25Exp: 2024-02-25→ Common Stock (1,762 underlying)
Footnotes (4)
- [F1]This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs.
- [F2]Includes 195 shares acquired under the Company's Employee Stock Purchase Plan through February 1, 2024.
- [F3]Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of RSUs.
- [F4]Each RSU represents a contingent right to receive one share of Company common stock.
Signature
/s/ Matthew R. St. Louis, Attorney-in-Fact for Rachel Ellingson (power of attorney previously filed))|2024-02-27